Bruker Corporation (FRA:BKD)
Germany · Delayed Price · Currency is EUR 32.70
-1.15 (-3.40%)
At close: Feb 20, 2026
Bruker Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 3,437 | 3,366 | 2,965 | 2,531 | 2,411 |
Other Revenue | - | - | - | - | 7.4 |
Revenue | 3,437 | 3,366 | 2,965 | 2,531 | 2,418 |
Revenue Growth (YoY) | 2.08% | 13.56% | 17.14% | 4.67% | 21.65% |
Cost of Revenue | 1,789 | 1,683 | 1,445 | 1,224 | 1,205 |
Gross Profit | 1,648 | 1,683 | 1,519 | 1,307 | 1,213 |
Selling, General & Admin | 946.5 | 892.5 | 729.5 | 608.4 | 563.4 |
Research & Development | 395.2 | 376.5 | 294.8 | 235.9 | 220.8 |
Other Operating Expenses | 71.3 | 3.8 | 5.9 | 3.2 | 3.9 |
Operating Expenses | 1,413 | 1,273 | 1,030 | 847.5 | 788.1 |
Operating Income | 234.9 | 410.3 | 489.1 | 459.1 | 424.9 |
Interest Expense | -29.8 | -47.9 | -16.4 | -16.1 | -14.3 |
Interest & Investment Income | - | 9.3 | 7.5 | 2.8 | 0.9 |
Earnings From Equity Investments | -1 | -1.7 | 2 | 1 | - |
Currency Exchange Gain (Loss) | - | 23.7 | -13.3 | -5.8 | -4.1 |
Other Non Operating Income (Expenses) | - | - | -3.1 | 1.3 | - |
EBT Excluding Unusual Items | 204.1 | 393.7 | 465.8 | 442.3 | 407.4 |
Merger & Restructuring Charges | -51.9 | -150.5 | -39 | -27.1 | -14.3 |
Impairment of Goodwill | -96.5 | - | - | - | - |
Gain (Loss) on Sale of Investments | -16.4 | -24.6 | -11.4 | - | - |
Asset Writedown | -18.3 | -2.2 | -5.7 | -0.3 | 0.5 |
Other Unusual Items | - | -11.2 | 136.5 | - | - |
Pretax Income | 21 | 205.2 | 546.2 | 414.9 | 393.6 |
Income Tax Expense | 29.3 | 91.4 | 117.7 | 116.4 | 113 |
Earnings From Continuing Operations | -8.3 | 113.8 | 428.5 | 298.5 | 280.6 |
Minority Interest in Earnings | -0.3 | -0.7 | -1.3 | -1.9 | -3.5 |
Net Income | -8.6 | 113.1 | 427.2 | 296.6 | 277.1 |
Preferred Dividends & Other Adjustments | 13.9 | - | - | - | - |
Net Income to Common | -22.5 | 113.1 | 427.2 | 296.6 | 277.1 |
Net Income Growth | - | -73.52% | 44.03% | 7.04% | 75.60% |
Shares Outstanding (Basic) | 152 | 149 | 146 | 149 | 151 |
Shares Outstanding (Diluted) | 152 | 150 | 147 | 149 | 153 |
Shares Change (YoY) | 1.54% | 1.56% | -1.47% | -2.29% | -1.10% |
EPS (Basic) | -0.15 | 0.76 | 2.92 | 2.00 | 1.83 |
EPS (Diluted) | -0.15 | 0.76 | 2.90 | 1.99 | 1.81 |
EPS Growth | - | -73.83% | 45.73% | 9.95% | 77.45% |
Free Cash Flow | 43.3 | 136 | 243.2 | 145.2 | 190.4 |
Free Cash Flow Per Share | 0.28 | 0.91 | 1.65 | 0.97 | 1.25 |
Dividend Per Share | 0.200 | 0.200 | 0.200 | 0.200 | 0.160 |
Dividend Growth | - | - | - | 25.00% | - |
Gross Margin | 47.95% | 50.00% | 51.25% | 51.63% | 50.17% |
Operating Margin | 6.83% | 12.19% | 16.50% | 18.14% | 17.57% |
Profit Margin | -0.66% | 3.36% | 14.41% | 11.72% | 11.46% |
Free Cash Flow Margin | 1.26% | 4.04% | 8.20% | 5.74% | 7.88% |
EBITDA | 455.2 | 594.1 | 604 | 547.9 | 514 |
EBITDA Margin | 13.25% | 17.65% | 20.37% | 21.65% | 21.26% |
D&A For EBITDA | 220.3 | 183.8 | 114.9 | 88.8 | 89.1 |
EBIT | 234.9 | 410.3 | 489.1 | 459.1 | 424.9 |
EBIT Margin | 6.83% | 12.19% | 16.50% | 18.14% | 17.57% |
Effective Tax Rate | 139.52% | 44.54% | 21.55% | 28.06% | 28.71% |
Revenue as Reported | - | 3,366 | 2,965 | 2,531 | 2,418 |
Advertising Expenses | - | 27.8 | 23.7 | 19.3 | 13.8 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.